g g g g g g g
1. Agclientgwithgaghistorygofgchronicgobstructivegpul- Primesgtheginhalergw
gmonarygdiseaseg(COPD)greceivesgagnew gprescriptio hg7gpumps.
ngforgangipratropiumginhaler.gWhichgactiongindicatesg
togthegnurse
thatgadditionalgteachinggisgneeded?
a. Primesgtheginhalergwithg7gpumps.
b. Attachesgspacergdevicegtogtheginhaler.
c. Rinsesgthegaftergeachguse.
d. Storesgthegmedicationgatgroomgtemperature.
2. Agclientgwithgheartgfailureg(HF)gdevelopsghyperaldos- Limitgintake
gteronismgandgspironolactonegisgprescribed.gWhichgin ofghigh-potassium
-
structiongshouldgthegnursegincludegingthisgclient'sgplang foods.
ofgcar
e?
Covergyourgskingbeforeggoinggoutside.
gLimitgintakegofghigh-
potassiumgfoods.gReplacegsaltgwithgag
saltgsubstitute.
Monitorgskingforgexcessivegbruising.
3. Agclientgwithgpepticgulcergdiseasegreceivesgagnewgpre- 4gcancer.gT
g
gscriptiongforgcimetidine.gWhichgstatementgprovidedg
hegclientgha
bygthegclientgrequiresgadditionalginstructiongbygthegn sgagprescri
urse? ptiongtogwe
a. Notifygtheghealthcaregprovidergofglethargy. arga
b. Monitorgforganygsignsgofgsexualgdysfunction.
c. Decreasegcigarettegusegtogagpackgpergday.
d. Takegthegmedicationganghourgaftergantacids
4. Agclientgwithgchemotherapyginducedgnauseagreceives
gagprescriptiongforgmetoclopramide.gWhichgadversegef
-gfectgisgmostgimportantgforgthegnursegtogreport?
a. Diarrhea.
b. Involuntarygmovements.
c. Unusualgirritability.
d. Nausea.
5. Thegnursegadmitsgagclientgwithgagdiagnosisgofgstage
1g/g48
, BSN 315 PHARM II PRACTICE QUESTIONS FOR HESI
g g g g g g g
Decreasegciga-grettegusegtogagpackgpergday
Involuntarygmove-gments.
Removegthegmor-gphinegpatches.
2g/g48
, BSN 315 PHARM II PRACTICE QUESTIONS FOR HESI
g g g g g g g
subcutaneousgmorphinegsulfategpatchgforgpain.gTheg a. Explaingth
gcolorgcha
clientgisgshortgofgbreathgandgdifficultgtogarouse.gWhile
gperforminggagheadgtogtoegassessment.gthegnursegdis
gegisgnorm
al.
-
b. Measuregt
gcoversgfourgpatchesgongthegclient'sgbody.Whichgactio
ngshouldgthegnursegtakegfirst? egclient'sg
a. Monitorgbloodgpressure. rinarygout
b. Administergagnarcoticgreversalgdrug. ut.
c. Removegthegmorphinegpatches.
d. Applygoxygengfacegmask.
6. Thegnursegisgprovidingginstructionsgaboutgagclient's
gnew gmedications.gHow gshouldgthegnursegexplaingth
egpurposegofgprobenecid,gaguricosuricgdrug?
a. Decreasesgpaingandgburninggduringgurination.
b. Preventsgthegformationgofgkidneygstones.
c. Increasesgthegstrengthgofgthegurinegstream.
d. Promotesgexcretiongofguricgacidgingthegurine.
7. Agclientgtakinggatorvastatingdevelopsgangincreasedgs
erumgcreatinegphosphokinaseg(CK)glevel.gThegnurseg
shouldgassessgthegclientgforgthegonsetgofgwhichgprob-
glem?
a. Excessivegbruising.
b. Musclegtenderness.
c. Peripheralgedema.
d. Nauseagandgvomiting.
8. Agclientgreceivesgagnewgprescriptiongforglevothyrox-
gine.gWhichgstatementgmadegbygclientgindicatesgtogth
egnursegthegeducationgwasgeffective?
a. Takegmedicationgongangemptygstomach.
b. Avoidgthegusegofgirongsupplements
c. Administerglevothyroxinegatgbedtime
gConsumegfoodsgthatgareghighgingiodine
.
9. AgclientgwithgParkinson'sgdiseasegwhogisgtakinggcar-
gbidopa/levodopagreportsgthegurinegappearsgtogbegda
rkergingcolor.gWhichgactiongshouldgthegnursegtake?
3g/g48
, BSN 315 PHARM II PRACTICE QUESTIONS FOR HESI
g g g g g g g
Promotesgexcre-gtiongofguricgacidgingthegurine.
Musclegtender-gness.
Takegmedicationgongangemptygstom-gach.
Explaingthegcolorgchangegisgnormal.
4g/g48